Daniel Nevo

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 7

Top Topics

Respiratory Syndrome Coronavirus

Ulcerative Colitis

Top Venues

Journal of Crohn's & colitis

Biostatistics (Oxford, England)

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Ohad Atia, Esther Orlanski-Meyer, Rona Lujan, Natan Ledderman, Shira Greenfeld, Revital Kariv, Saleh Daher, Henit Yanai, Yiska Loewenberg Weisband, Hagit Gabay, Eran Matz, Daniel Nevo, Jacob Ollech, Eran Zittan, Eran Israeli, Doron Schwartz, Yehuda Chowers, Iris Dotan, Dan Turner
Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN. Journal of Crohn's & colitis 16 (5) (2022)
Rachel Axelrod, Daniel Nevo
A sensitivity analysis approach for the causal hazard ratio in randomized and observational studies. Biometrics (2022)
Samah Hayek, Galit Shaham, Yatir Ben-Shlomo, Eldad Kepten, Noa Dagan, Daniel Nevo, Marc Lipsitch, Ben Y Reis, Ran D Balicer, Noam Barda
Indirect protection of children from SARS-CoV-2 infection through parental vaccination. Science (New York, N.Y.) 375 (6585) (2022)
Daniel Nevo, Malka Gorfine
Causal inference for semi-competing risks data. Biostatistics (Oxford, England) 23 (4) (2022)
Daniel Nevo, Shuji Ogino, Molin Wang
Reflection on modern methods: causal inference considerations for heterogeneous disease etiology. International journal of epidemiology 50 (3) (2021)
Daniel Nevo, Deborah Blacker, Eric B Larson, Sebastien J-P A Haneuse
Modeling semi-competing risks data as a longitudinal bivariate process. Biometrics (2021)
Ohad Atia, Esther Orlanski-Meyer, Rona Lujan, Natan Ledderman, Shira Greenfeld, Revital Kariv, Saleh Daher, Henit Yanai, Yiska Loewenberg Weisband, Hagit Gabay, Eran Matz, Daniel Nevo, Eran Israeli, Doron Schwartz, Yehuda Chowers, Iris Dotan, Dan Turner
Improved outcomes of pediatric and adult Crohn's disease and association with emerging use of biologics - a nationwide study from the epi-IIRN. Journal of Crohn's & colitis (2021)